Patent ID: 8592370

Claim:
A pharmaceutical composition comprising insulin in combination with at least one compound of formula (I) and/or physiologically acceptable salts thereof, wherein the compound of formula (I) is defined as follows: in which R 1 , R 2 each, independently of one another, denote H or A, R 3 , R 4 each, independently of one another, denote H, A, alkenyl having 2-6 C atoms, alkynyl having 2-6 C atoms, Ar or Het, R 5 , R 6 each, independently of one another, denote H, A, (CH 2 ) n Ar, (CH 2 ) m OAr, (CH 2 ) m OA or (CH 2 ) m OH, R 5 and R 6 together also denote alkylene having 2, 3, 4 or 5 C atoms, in which one CH 2 group may be replaced by O, NH or NA and/or in which 1 H atom may be replaced by OH, Ar denotes phenyl, naphthyl or biphenyl, each of which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OA, OH, COOH, COOA, CN, NH 2 , NHA, NA 2 , SO 2 A and/or COA, Het denotes a mono-, bi- or tricyclic saturated, unsaturated or aromatic heterocycle having 1 to 4 N, O and/or S atoms, which may be unsubstituted or mono-, di- or trisubstituted by Hal, A, OH, OA, NH 2 , (CH 2 ) n Ar, NHA, NA 2 , COOH, COOA and/or ═O (carbonyl oxygen), A denotes unbranched or branched alkyl having 1-10 C atoms, in which 1-7 H atoms may be replaced by F, or cyclic alkyl having 3-7 C atoms, Hal denotes F, Cl, Br or I, m denotes 1, 2, 3, 4, 5 or 6, and n denotes 0, 1 or 2.